세계의 수술 중 신경 모니터링 시장 : 제품·서비스별, 소스 유형별, 용도별, 최종 용도별, 지역별 - 예측 분석(2022-2028년)
Global Intraoperative Neuromonitoring Market By product & services, By source type, By application, By end use, & By region-Forecast Analysis 2022-2028
세계의 수술 중 신경 모니터링 시장 규모는 2021년 36억 3,000만 달러에서 2028년에는 46억 1,000만 달러에 이를 것으로 예상되며, 2022년부터 2028년까지 예측 기간 중 연평균 복합 성장률(CAGR)은 4.53%를 나타낼 것으로 예측됩니다.
세계의 수술 중 신경 모니터링(IONM: Intraoperative Neuromonitoring) 시장에 대해 조사분석했으며, 시장 개요, 시장 규모, 시장 역학, 기업 개요 등의 정보를 제공합니다.
Global Intraoperative Neuromonitoring market was valued at USD 3.63 billion in 2021, and is expected to reach a value of USD 4.61 billion by 2028, at a CAGR of 4.53% over the forecast period (2022-2028).
The market is expanding as a result of the increased focus on patient safety during challenging surgical procedures and the rising incidence of chronic illnesses such stroke, epilepsy, Alzheimer's disease, Parkinson's disease, and stroke. According to the WHO, neurological illnesses impact hundreds of millions of people globally. Worldwide, 15 million people experience a brain stroke each year. The market has expanded as a result of this.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intraoperative Neuromonitoring market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The Global Intraoperative Neuromonitoring Market is segmented based on product & service, source type, application, end-user, and region. Based on Product & Service it is categorized into Systems, Accessories, and Services. Based on Source Type it is categorized into Insourced Monitoring and Outsourced Monitoring. Based on Application it is categorized into Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, and Orthopaedic Surgery. Based on End-User it is categorized into Hospitals and Ambulatory Surgical Centres. Based on the region it is categorized into North America, Europe, Asia Pacific, South America, and MEA.
Neurological issues are common and are associated with prolonged hospitalizations in the intensive care unit (ICU) in critically ill COVID-19 patients receiving invasive mechanical ventilation, according to Frontiers Media S.A. in November 2020. Multimodal noninvasive neuromonitoring technologies were effective instruments for the early diagnosis of anomalies in cerebrovascular parameters during the pandemic. Additionally, more stringent patient education, recovery room assessment for non-ICU hospitalization, quicker mobilization, post-discharge communication, expanding acceptance of less invasive operations, and early post-imaging are all advised. Significant prospects for market expansion are anticipated as a result of these reasons.
The intraoperative neuromonitoring market will be severely hampered by the high cost of IONM equipment and procedures. Depending on the number of channels, EEG devices with 1-32 channels can cost anywhere between US$ 1,000 and US$ 25,000, while those with more than 64 channels may cost more than US$ 25,000. Typically, portable amplifiers that can record EMG for longer than four hours cost around US$ 20,000. Many end users choose refurbished IONM devices over new ones due to financial restrictions because they provide significant cost savings. Refurbished IONM devices are sold by a number of businesses, including Alternative Source Medical. This decreases the demand for new IONM devices from well-known suppliers that make significant investments in R&D to create cutting-edge IONM devices. These elements are anticipated to restrict market expansion in
The prevalence of neurovascular illnesses is predicted to rise, increasing the demand for sophisticated intraoperative neuromonitoring devices and minimally invasive/noninvasive intraoperative neuromonitoring systems. Additionally, the majority of nations have begun to relax the rules on lockdowns and have resumed performing some elective surgery. The market is therefore anticipated to bounce back and expand during the forecast period. To deal with supply chain disruptions, businesses have been utilizing tactics like rerouting logistics, sourcing from extra partners, and air freight delivery. Major companies also want to geographically expand their operations and build more warehouses in various locations in order to conduct their business through the many accessible channels in the worst-affected areas and meet the rising demand.
These elements are anticipated to produce profitable expansion opportunities.
Wheel of Fortune
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations
Parent Market Analysis
Key Market Insights
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
Raw Material Analysis
Pipeline Product Analysis
Top Investment Analysis
Key Success Factor
Degree of Competition
Market Dynamics & Outlook
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
Global Intraoperative Neuromonitoring Market by Product & Services
Global Intraoperative Neuromonitoring Market by Source Type